20 March 2025 : Clinical Research
Exploring the Association Between Serum Neurogranin, Nardilysin, and Ischemic Stroke: A Case-Control Study Conducted in the Emergency Department
Habibe Selmin OzensoyDOI: 10.12659/MSM.947703
Med Sci Monit 2025; 31:e947703
Table 3 Comparison of Ng, NRDC, other biomarkers, and blood cell count parameters between IS patients and controls.
| ISVD-patient Group (n) | Control Group (n) | P | |
|---|---|---|---|
| Ng (pg/mL) | 281.12±32.12 | 265.71±24.54 | |
| NRDC (ng/mL) | 6.35±4.13 | 6.99±4.16 | 0.47 |
| Aspartate amino transferase (U/L) | 36.75 ±34.03 | 25.79±8.19 | |
| Alanine amino transferase (U/L) | 29.27±31.52 | 23.11±8.15 | 0.2 |
| Urea (mg/dL) | 47±21.61 | 34.9±14.37 | 0.003 |
| Creatine (mg/dL) | 1.01±0.41 | 0.84±0.21 | 0.02 |
| White blood cells (×10/L) | 7.776±2.414 | 8.423±2.607 | 0.23 |
| Hemoglobin (g/dL) | 12.11±1.79 | 12.99±1.69 | |
| Platelet (×10/L) | 244.818±1.051 | 270.272±74.741 | 0.194 |
| Neutrophil (×10/L) | 5.053±1.967 | 5.400±2.335 | 0.45 |
| Lymphocyte (×10/L) | 1.801±798 | 2.181±0.829 | |
| Ng – neurograninl NRDC – Nardilysin; IS – ischemic stroke. | |||






